3,622 research outputs found

    BestMap: context-aware SKOS vocabulary mappings in OWL 2

    No full text
    This paper describes an approach to SKOS vocabulary mapping that takes into account the context in which vocabulary terms are used in annotations. The standard vocabulary mapping properties in SKOS only allow for binary mappings between concepts. In the BestMap ontology, annotated resources are the contexts in which annotations coincide and allow for a more fine grained control over when mappings hold.A mapping between two vocabularies is defined as a class that groups descriptions of a resource. We use the OWL 2 features for property chains, disjoint properties, union, intersection and negation together with careful use of equivalence and subsumption to specify these mappings

    Publishing and Consuming Linked Data

    No full text
    Harmelen, F.A.H. van [Promotor]Schlobach, K.S. [Copromotor]Hoekstra, R.J. [Copromotor

    R.J. Sommers

    No full text
    The single-spaced paragraph on the “About the Author” page of R.J. Sommers’ latest novel says she lives in a one-story house on the edge of a city. It says she is renowned for writing relatable characters and compelling relationships. It says nothing about her own friends. Gazing from a photo at the top of the page, R.J. Sommers appears to point a camera toward her readers..

    Stadsentrees: Ontwerp-ingrepen als oplossing voor knelpunten in de Haagse stadsentrees

    No full text
    Dit afstudeerproject was een ontwerponderzoek dat keek naar hoe de stadsentree kan worden her gepositioneerd en geïntegreerd in het stedelijk weefsel. Dit project had als onderzoeksdoel om het onderwerp stadsentrees te verkennen. Het ontwerpdoel was om een huidige stadsentree te versterken in ruimtelijke en functionele zin. De onderzoeksvraag luidt: ‘Wat zijn de knelpunten in de belangrijkste stadsentrees van Den Haag, met welke ontwerp-ingrepen kunnen deze knelpunten worden opgelost en wat valt hieruit te leren voor stadsentrees van andere Nederlandse steden?’.UrbanismArchitecture and The Built Environmen

    A Cognitive Science Perspective on Legal Ontologies

    No full text
    We can trace five origins of ontology engineering, and all five still play a major role in ontology engineering. Each of these roots gives a different perspective on content and use of ontologies. Philosophical ontology is concerned with "reality"; Information science with systematic terminology; Artificial Intelligence (AI) with terminological knowledge, Knowledge Engineering with the specification of knowledge bases, and Information Management with semantics. Associated with these roots, the applications differ and range from analytic clarification to automated reasoning. Also mismatches between formalism and aim occur frequently. These mismatches can often be traced to an unclear distinction between knowledge and semantics. We explain this difference in Section 4.3 using a simple cognitive architecture for natural language production. A Cognitive Science perspective is however well suited where top ontologies try to cover the core concepts of common sense, as a wealth of empirical studies have become available on the content of our "knowledge instincts". We present an example on the modeling of spatial concepts and refer to our still ongoing work on a common-sense based core ontology for legal domains: LKIF-Core (Hoekstra et al. 2007; Hoekstra 2009). <br/

    Interviewen

    No full text
    Interviewen is een veelvoorkomende wetenschappelijke methode on informatie teverzamelen. Belangrijk is dat het interview inhoudelijk goed aansluit bij jouwontwerpopgave of onderzoek. Daarnaast helpt het enorm om te werken met eensystematische aanpak bij het vastleggen, ordenen, analyseren en rapporteren vande informatie uit je interviews. En natuurlijk is een goede gespreksvoorbereidingbelangrijk. De interviewmethode omvat drie fasen:1. Voorbereiding en randvoorwaarden2. Uitvoering, gespreksvoering en vastleggen data, en3. Uitwerking, analyse en rapportage.Interviews zijn zeer geschikt voor het in kaart brengen van percepties, ervaringen,opvattingen, verwachtingen, en het ophalen van kennis uit de praktijk. Om decomplexiteit van datgene wat je onderzoekt te begrijpen, is het van belang dat je inhet interview zelf flexibel kunt opereren. Gesprekken verlopen nog al eens andersdan tijdens de voorbereiding wordt verondersteld. Dit hoofdstuk biedt concretehandvaten voor alle onderdelen van het proces.Urban StudiesSpatial Planning and Strateg

    Clinical and experimental studies on the pathogenesis and the rol of bile salts

    No full text
    Chapter 1 provides a short introduction and the outline of this thesis. The aim of the thesis was to identify clinical risk factors for non-anastomotic strictures (NAS), by analyzing donor and patient characteristics, as well as surgical variables in relation to postoperative outcome after orthotopic liver transplantation (OLT). Furthermore, we have performed clinical studies and experimental studies in mice to unravel the role of bile salt toxicity in the pathogenesis of hepatobiliary injury after OLT. The thesis is divided in two parts. The first part focuses on the clinical risk factors for the development of NAS and in the second the part we investigate the role of toxic bile salts and bile secretory function in the development of hepatobiliary injury after OLT. Part I. Non-anastomotic biliary strictures after liver transplantation Chapter 2 provides an overview of the literature regarding the causes and consequences of NAS, also called ischemic-type biliary lesions (ITBL). The aim of this chapter is to describe the pathophysiological mechanisms, clinical presentation and the treatment of NAS. NAS is a radiological diagnosis, characterized by intrahepatic strictures and dilatations on cholangiography. NAS were first described after liver transplantation in association with hepatic artery thrombosis (HAT). In case of early HAT the bile duct becomes ischemic; resulting in a typical cholangiographic picture of biliary strictures, dilatations and intraductal cast formation. However, these abnormalities can also be seen in the absence of HAT, hence the term ischemic-type biliary lesions emerged. In this thesis the term NAS was used to describe intrahepatic biliary strictures and dilations of the bile duct in patients without HAT. The incidence of NAS varies around 15% in different series reported in literature. Various risk factors for NAS have been identified, strongly suggesting a multifactorial origin. The main categories include ischemia-related injury, immune-mediated injury and toxic injury by bile salts. Nevertheless, in many cases no specific risk factor can be identified. The clinical presentation of patients with NAS is often not specific. Symptoms may include fever, abdominal complaints and increased cholestatic liver function tests. The diagnosis is made by imaging studies of the bile ducts. Treatment starts with relieving symptoms of cholestasis and dilation of stenosed bile ducts via endoscopic retrograde cholangiopancreaticography (ERCP) or percutaneous transhepatic cholangiodrainage (PTCD), if possible followed by stenting. Eventually up to 50% of the patients with NAS may require retransplantation or may die. In selected cases, retransplantation can be avoided or delayed by surgical intervention. 158 In the clinical study described in chapter 3 we aimed to determine whether Roux-Y choledochojejunostomy is an independent risk factor for NAS after transplantation. A total of 486 adult liver transplant recipients, transplanted between May 1992 and June 2006 with a median postoperative follow-up of 5.6 years, were included in this study. One- and 5-year patient survival rates were 85.4 and 77.2%, respectively. Graft survival rates at 1- and 5-years were 80.2% and 69.1%, respectively. NAS was observed in 80 of the 486 (16.5%) transplanted livers at a median time interval of 4.1 months after OLT. A total of 18 potential risk factors for NAS were studied by comparing the group of patients with NAS with those who did not develop NAS. Risk factors were grouped as donor or recipient-related variables, surgical variables and postoperative outcome variables. A univariate comparison of these demographic and clinical variables between patients with and without NAS indicated primary sclerosing cholangitis (PSC), the type of bile duct reconstruction and postoperative cytomegalovirus (CMV) infection as risk factors for NAS. In patients who were transplanted for PSC, the incidence of NAS was two-fold higher than in patients transplanted for other indications. In addition, NAS were observed significantly more frequent when Roux-Y choledochojejunostomy was used for biliary reconstruction, compared to patients with a duct-to-duct biliary reconstruction. However, after multivariate regression analysis, including variables previously reported in literature as important risk factors for the development of NAS, Roux-Y choledochojejunostomy was not identified as independent risk factor for NAS. Based on the results of this study, it was concluded that the association between Roux-Y choledochojejunostomy and NAS that has been observed in previous studies can be explained entirely by the more frequent use of Roux-Y reconstruction in patients with PSC. Bacterial migration and (recurrent) ascending cholangitis as can be seen more frequently in patients with a Roux-Y reconstruction, apparently do not play a role in the pathogenesis of NAS after transplantation. In chapter 4, outcome after transplantation is compared for livers from brain death (DBD) or cardiac death (DCD) donors performed in The Netherlands between January 2001 and December 2006. Of a total of 526 transplant procedures performed in this time period, in 55 cases a liver from a DCD donor was used and in 471 cases a liver from a DBD donor was used. A national protocol was introduced for multiorgan donation (MOD) of organs from controlled DCD donors. All three participating Dutch liver transplant centers agreed to allocate livers from DCD donors according 159 to the national waiting list. There were no significant differences in the overall 1- and 3-year patient survival rates after DCD and DBD liver transplantation (84.6% versus 80.4%, and 86.3% versus 80.8%, respectively). Overall 1- and 3- year graft survival did also not differ between DCD and DBD liver transplantation (74.0% versus 67.9%, and 80.5% versus 74.7%, respectively), although significant differences in the rate of graft loss were observed between centers. NAS was observed significantly more frequently after DCD liver transplantation (23.6% versus 7.9%, DCD versus DBD, respectively), requiring significantly more retransplantations (10.9% versus 2.5%, DCD versus DBD). Risk factors for graft loss and NAS were grouped as donor and recipients related variables, surgical, and postoperative outcome variables. Multivariate regression analysis revealed transplant center, first warm ischemic and cold ischemic time as independent risk factors for 1-year graft survival in DCD liver transplantation. In a multivariate regression analysis the following independent risk factors for NAS were identified: DCD liver grafts, donor age, and PSC. Part II . The role of bile salts in the pathogenesis of hepatobiliary injury after liver transplantation In chapter 5 we investigated the role of endogenous bile salts in the origin of bile duct injury after OLT in a mouse model of arterialized liver transplantation. Previously, Geuken et al. suggested that an increased biliary bile salt/phospholipid ratio early after OLT, leading to toxic bile composition, may result in increased intrahepatic bile duct injury (1). However, formal evidence for a cause-effect relationship between toxic bile formation and bile duct injury after OLT could not be established by this observational clinical study. In fact, it could not be ruled out that toxic bile composition and bile duct injury both resulted from the same underlying factor. By comparing outcome after transplantation of livers from wild-type mice or mice heterozygous for the disruption of the Mdr2 gene (Mdr2+/-), we demonstrated that endogenous bile salts act synergistically to ischemia/reperfusion in the origin of bile duct injury. This study provided evidence that bile salt toxicity is an important factor that may contribute to hepatobiliary injury after OLT. In chapter 6 the involvement of bile secretory function in the pathogenesis of hepatobiliary injury after the occurrence of HAT was investigated. In contrast to the liver parenchyma, the bile ducts have a single blood supply that comes entirely from 160 the hepatic artery. HAT is a well known risk factor for the development of ischemic bile duct strictures after OLT. Although ischemic injury of the bile ducts is a key mechanism, it was unknown whether changes in bile composition may contribute to the development of biliary injury in this situation as well. Previous studies have indicated that hepatic arterial blood flow is critical for the recovery of hepatocyte bile secretory function after OLT (2). In the absence of bile secretion, bile salts can accumulate and act cytotoxic on hepatocytes and cholangiocytes. To study whether changes in bile secretion could play a role in the pathogenesis of hepatobiliary injury in the event of HAT, we developed a mouse model of impaired arterial perfusion of the liver induced by ligation of either the hepatic artery or the peribiliary plexus, or a combination of the two. Ligation of either the hepatic artery or the peribiliary plexus did not result in marked histological, biochemical or molecular changes. This means that the hepatic artery and peribiliary plexus both have the capacity to provide sufficient blood supply to the biliary tree in this model. The combination of hepatic artery ligation and interruption of the peribiliary plexus (complete loss of arterial blood supply to the liver), however, resulted in severe injury of the bile ducts and liver parenchyma, with two out of five animals dying after 14 days. As early as 24 hours after complete dearterialization, in the absence of hepatobiliary injury, liver ATP-levels were significantly decreased, and gene expression for the bile salt transporter Ntcp and Bsep decreased and serum conjugated bile salt levels increased, subsequently. Pro-inflammatory cytokine release was slowly induced and intrahepatic cholestasis progressed in the following weeks. This study demonstrated that the expression of hepatobiliary transporters is dysregulated early after complete loss of arterial blood supply to the liver, leading to intrahepatic cholestasis and bile salt-mediated injury. These data suggest that hepatobiliary injury frequently seen when HAT occurs after OLT, may not only be due to a direct ischemic injury, but is also related to bile saltmediated injury. The study described in chapter 7 provides new insights in the role of cholangiocyte bile salt transporters in biliary injury after OLT in mice. Cholangiocytes express various bile salt transporters such as Asbt and heteromeric Ost-alpha/beta, responsible for the uptake and secretion of bile salts, respectively. We analyzed gene and protein expression for these transporters in our previously established mouse OLT model. To determine the impact of biliary bile salts and the bile salt/phospholipid ratio on the expression 161 of these transporters, we compared livers transplanted from Mdr2+/- mice with livers from wild-type donors. Since changes in cholangiocyte transporter expression are associated with hepatic pro-inflammatory cytokine release, we also assessed the hepatic expression for TNF-alpha and IL1-beta in the donor livers and correlated this with the expression levels of the cholangiocyte transporters. Transplantation of Mdr2+/- livers resulted in down-regulation of mRNA expression for Asbt, Ost-beta and Ost-alpha after OLT. Asbt expression appeared to be regulated in direct proportion to the biliary bile salt/phospholipid ratio, whereas Ost-alpha/beta expression correlated negatively with the expression for TNF-alpha and IL1-beta. The unbalanced reduction of Asbt and Ost-alpha/beta expression after OLT therefore, may result in bile salt retention in cholangiocytes, cytotoxicity and aggravate bile duct injury. In chapter 8 we have examined changes in the expression of cholangiocyte bile transporters and the cholehepatic shunt in patients after OLT in humans. Expression of ASBT, OST-alpha/beta and CFTR was determined in liver transplant biopsies and levels of expression were correlated with biliary bile salt secretion and the development of microscopic bile duct injury at one week after transplantation. OST-alpha transcript levels were significantly down-regulated at the end of cold storage and immediately after graft reperfusion, but levels had restored to normal values at one week after OLT. OST-beta mRNA expression was more than 8-fold up-regulated at the end of cold preservation and after graft reperfusion and increased further during the first week after OLT. Overall the immunofluorescence staining pattern of these two transporters was similar. The observed changes in the expression of the bile salt transporters OST-alpha and OST-beta correlate with biliary bile salt secretion, but not with the degree of bile duct injury. Although increased uptake of bile salts through cholangiocytes has been linked with an increased expression for CFTR, we found no major changes in CFTR mRNA expression. Altogether, these data suggest that the cholehepatic shunt does not play a major role in the development of bile salt induced bile duct injury after OLT. 162 Collectively, the studies described in Part II of this thesis indicate that bile salt toxicity and intrahepatic cholestasis are key events contributing to hepatobiliary injury after OLT. Therapeutic strategies to prevent hepatobiliary injury after OLT therefore should focus on options to alter bile composition and to maintain choleresis. Drugs that could potentially reduce this type of injury should target at bile composition and the affected bile duct epithelium itself, and ideally should also have anti-cholestatic, anti-inflammatory and anti-fibrotic properties. Ursodeoxycholic acid (UDCA) is known to improve cholestatic disorders and is widely used in the treatment of patients with cholestatic liver diseases. Several mechanisms may potentially contribute to the beneficial effect of UDCA after human OLT. Under cholestatic conditions, UDCA stimulates hepatocyte secretion of bile salts, inhibits bile salt induced hepatocyte (and cholangiocyte) apoptosis, protects injured cholangiocytes against the toxic effects of endogenous bile salts, and/or stimulates Cl- and HCO3- secretion into bile via CFTR (3). In contrast to UDCA, its side chain-shortened homologue nor-UDCA undergoes cholehepatic shunting leading to a bicarbonate-rich hypercholeresis. Nor-UDCA has anti-inflammatory, anti-proliferative and anti-fibrotic effects, and stimulates bile salt detoxification. This drug may be potentially of benefit in patients undergoing OLT and may reduce the incidence and severity of biliary injury leading to NAS. Finally, drugs that can affect biliary phospholipid and bile salt excretion via nuclear receptors (FXR, PPAR-alpha) could theoretically be of benefit as a prophylactic approach to prevent bile salt-induced biliary injury after OLT. Time has come to design and initiate clinical studies. An attractive fist option to study will be the potential benefits of UDCA or nor- UDCA in liver transplant recipients. Since NAS is frequently observed after DCD liver transplantation, this category of patients could be an attractive focus for future research. The efficacy of UDCA or nor-UDCA should ideally be evaluated in a large-scale multicenter placebo-controlled randomized trial in DCD liver transplant recipients. Initiatives for such a multicenter study have recently been taken. 163 References 1. Geuken E, Visser D, Kuipers F, Blokzijl H, Leuvenink HG, de Jong KP, Peeters PM, et al. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol 2004;41:1017-1025. 2. Wheatley AM. Hepatic artery and post-transplantation hemodynamics and function. Am J Transplant 2004;4:290; author reply 291. 3. Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006;3:318-328. 164status: Publishe

    Author Co-Citation Analysis (ACA): a powerful tool for representing implicit knowledge of scholar knowledge workers

    No full text
    In the last decade, knowledge has emerged as one of the most important and valuable organizational assets. Gradually this importance caused to emergence of new discipline entitled ―knowledge management‖. However one of the major challenges of knowledge management is conversion implicit or tacit knowledge to explicit knowledge. Thus Making knowledge visible so that it can be better accessed, discussed, valued or generally managed is a long-standing objective in knowledge management. Accordingly in this paper author co- citation analysis (ACA) will be proposed as an efficient technique of knowledge visualization in academia (Scholar knowledge workers)
    corecore